More recently, a new VCP/p97 ATPase activity inhibitor, OSSL_325096, with a chemical structure similar to DBeQ, was identified using a cell-based screen designed to identify novel small molecules against multiple myeloma (MM). This evidence concerns the gene VCP and plasma cell myeloma.